586 related articles for article (PubMed ID: 15960988)
1. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.
Heidbreder CA; Gardner EL; Xi ZX; Thanos PK; Mugnaini M; Hagan JJ; Ashby CR
Brain Res Brain Res Rev; 2005 Jul; 49(1):77-105. PubMed ID: 15960988
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference.
Gyertyán I; Gál K
Neuroreport; 2003 Jan; 14(1):93-8. PubMed ID: 12544838
[TBL] [Abstract][Full Text] [Related]
3. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.
Gilbert JG; Newman AH; Gardner EL; Ashby CR; Heidbreder CA; Pak AC; Peng XQ; Xi ZX
Synapse; 2005 Jul; 57(1):17-28. PubMed ID: 15858839
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction.
Xi ZX; Gardner EL
CNS Drug Rev; 2007; 13(2):240-59. PubMed ID: 17627675
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.
Gál K; Gyertyán I
Drug Alcohol Depend; 2006 Jan; 81(1):63-70. PubMed ID: 16005579
[TBL] [Abstract][Full Text] [Related]
6. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?
Boulay D; Depoortere R; Perrault G; Sanger DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jan; 24(1):39-49. PubMed ID: 10659982
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
[TBL] [Abstract][Full Text] [Related]
8. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.
Millan MJ; Seguin L; Gobert A; Cussac D; Brocco M
Psychopharmacology (Berl); 2004 Jul; 174(3):341-57. PubMed ID: 14985929
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.
Khroyan TV; Barrett-Larimore RL; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2000 Aug; 294(2):680-7. PubMed ID: 10900248
[TBL] [Abstract][Full Text] [Related]
10. Lack of discrimination by agonists for D2 and D3 dopamine receptors.
Burris KD; Pacheco MA; Filtz TM; Kung MP; Kung HF; Molinoff PB
Neuropsychopharmacology; 1995 Jul; 12(4):335-45. PubMed ID: 7576010
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice.
Boulay D; Depoortere R; Rostene W; Perrault G; Sanger DJ
Neuropharmacology; 1999 Apr; 38(4):555-65. PubMed ID: 10221759
[TBL] [Abstract][Full Text] [Related]
12. Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors.
Brudzynski SM; Komadoski M; St Pierre J
Behav Brain Res; 2012 Jan; 226(2):511-8. PubMed ID: 22015714
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents.
Newman AH; Grundt P; Nader MA
J Med Chem; 2005 Jun; 48(11):3663-79. PubMed ID: 15916415
[No Abstract] [Full Text] [Related]
14. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors.
Bristow LJ; Cook GP; Patel S; Curtis N; Mawer I; Kulagowski JJ
Neuropharmacology; 1998 Jun; 37(6):793-802. PubMed ID: 9707293
[TBL] [Abstract][Full Text] [Related]
16. Targeting the dopamine D3 receptor cannot influence continuous reinforcement cocaine self-administration in rats.
Gál K; Gyertyán I
Brain Res Bull; 2003 Oct; 61(6):595-601. PubMed ID: 14519456
[TBL] [Abstract][Full Text] [Related]
17. Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence.
Heidbreder C
CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):410-21. PubMed ID: 19128200
[TBL] [Abstract][Full Text] [Related]
18. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
Siuciak JA; Fujiwara RA
Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923
[TBL] [Abstract][Full Text] [Related]
19. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
Piercey MF; Hyslop DK; Hoffmann WE
Brain Res; 1997 Jul; 762(1-2):19-28. PubMed ID: 9262154
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.
Bowery BJ; Razzaque Z; Emms F; Patel S; Freedman S; Bristow L; Kulagowski J; Seabrook GR
Br J Pharmacol; 1996 Dec; 119(7):1491-7. PubMed ID: 8968560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
